Black Diamond Therapeutics
Price & Volume
Stats
See more52W Range | $1.60-$4.94 |
Market Cap | $100.2M |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.77 |
News
See moreYahoo Finance • last month
Black Diamond Therapeutics to Participate in Jefferies Global Healthcare Conference
Yahoo Finance • last month
Black Diamond Therapeutics Announces Positive Phase 2 Results for Silevertinib in Frontline NSCLC Patients with EGFR Non-Classical Mutations
Yahoo Finance • last month
MTVA Gains Weight, CODX Takes A Shot At Ebola, EDSA To Reveal New Data, BDTX On Watch
About
CEO | Dr. Mark A. Velleca M.D., Ph.D. |
Address | 245 First Street, Cambridge, MA, United States, 02142 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 21 |